Table 2.
All Patients (N=100) | Baseline MRCI score, mean (95% CI) | |
---|---|---|
Age, mean ± SD, y | 9.5 ± 0.6 | 32.6 (29.3–35.8) |
Sex, n (%), male | 58 (58) | 32.6 (28.3–36.9) |
Race, n (%) | ||
White | 53 (53) | 33.7 (29.3–38.0) |
Other | 20 (20) | 30.5 (23.4–37.5) |
Black or African American | 12 (12) | 35.5 (21.3–49.7) |
>1 Race | 7 (7) | 25.7 (22.2–29.2) |
Asian | 6 (6) | 36.4 (27.2–45.7) |
American Indian or Alaskan Native | 1 (1) | 26.5 |
Unknown | 1 (1) | 12.5 |
Ethnicity, n (%) | ||
Hispanic or Latino | 53 (53) | 30.4 (26.8–33.9) |
Not Hispanic or Latino | 46 (46) | 35.5 (29.9–41.2) |
Unknown | 1 (1) | 12.5 |
Insurance type, n (%) | ||
Public | 83 (83) | 31.6 (28.0–35.2) |
Private | 17 (17) | 37.2 (30.0–44.4) |
High-risk medications, n (%) | ||
0–1 | 39 (39) | 27.4 (23.6–31.3) |
2–3 | 30 (30) | 28.6 (24.4–32.8) |
≥4 | 31 (31) | 42.9 (35.6–50.2) |
Any compounded medications, n (%) | ||
Yes | 14 (14) | 32.7 (23.2–42.2) |
No | 86 (86) | 32.6 (29.1–36.0) |
Complex chronic conditions, n (%) | ||
0 | 11 (11) | 26.5 (15.6–37.4) |
1–2 | 47 (47) | 29.6 (25.1–34.0) |
≥3 | 42 (42) | 37.6 (32.8–42.3) |
Outpatient visits in past year, n (%) | ||
0–9 | 55 (55) | 27.5 (23.9–31.2) |
10–19 | 27 (27) | 33.2 (27.3–39.1) |
20–29 | 11 (11) | 51.3 (41.1–61.5) |
≥30 | 7 (7) | 40.6 (27.2–53.9) |